Idiopathic myelofibrosis: pathogenesis, natural history and management
- 1 December 1997
- journal article
- review article
- Published by Elsevier in Blood Reviews
- Vol. 11 (4) , 233-242
- https://doi.org/10.1016/s0268-960x(97)90022-9
Abstract
No abstract availableKeywords
This publication has 80 references indexed in Scilit:
- Bone marrow and serum connective tissue polypeptides in idiopathic myelofibrosisClinical and Laboratory Haematology, 2008
- PATHOGENESIS OF IDIOPATHIC MYELOFIBROSIS: PRESENT STATUS AND FUTURE DIRECTIONSBritish Journal of Haematology, 1994
- IDIOPATHIC MYELOFIBROSIS: ANAEMIA MAY RESPOND TO LOW-DOSE DEXAMETHASONEBritish Journal of Haematology, 1994
- RECOMBINANT HUMAN ERYTHROPOIETIN THERAPY IN PATIENTS WITH MYELOFIBROSIS WITH MYELOID METAPLASIABritish Journal of Haematology, 1994
- Raised urinary calmodulin levels in idiopathic myelofibrosis: possible implications for the aetiology of fibrosisBritish Journal of Haematology, 1994
- Serum erythropoietin in patients with myelofibrosis with myeloid metaplasiaBritish Journal of Haematology, 1993
- Characterization of an acute micromegakaryocytic leukaemia: evidence for the pathogenesis of myelofibrosisBritish Journal of Haematology, 1993
- Development of acute leukaemia after idiopathic myelofibrosis.Journal of Clinical Pathology, 1992
- Interferon‐γin vivo reverses the increased platelet levels of platelet‐derived growth factor and transforming growth factor‐β in patients with myelofibrosis with myeloid metaplasiaBritish Journal of Haematology, 1991
- The Syndrome of Idiopathic MyelofibrosisMedicine, 1983